Skip to main content

Table 1 Baseline, diagnosis and outcomes overall and according to HIV status

From: The utility of a shortened palliative care screening tool to predict death within 12 months – a prospective observational study in two south African hospitals with a high HIV burden

 

All

HIV-uninfected

HIV-unknown

HIV-infected

 

N (822)

(%)

N (440)

(53.50%)

N (204)

(24.80%)

N (178)

(21.70%)

Gender, n (%)

 Male,

378

(46.0)

234

(53.2)

70

(38.9)*

66

(37.1)*

 Female

444

(54.0)

206

(46.8)

110

(61.1)

112

(62.9)

Age

        

 Median (IQR)

52

(37–67)

50

(39–62)

71

(60–78)*

35

(30–44)*

Primary diagnosis

        

 Infection (other than TB)

145

(19)

55

(13.3)

26

(16.0)

54

((31.6)*

 Tuberculosis

92

(12)

32

(7.7)

4

(2.5)*

56

(32.7)*

 Acute coronary syndrome

93

(12)

50

(12.1)

40

(24.7)*

2

(1.2)*

 Stroke

66

(8)

28

(9.2)

28

(17.3)*

6

(3.5)*

 CCF

60

(8)

38

(6.8)

8

(4.9)

6

(3.5)*

 COPD

38

(5)

28

(6.8)

8

(4.9)

2

(1.2)*

 Cancer

28

(4)

18

(4.3)

4

(2.5)

6

(3.5)

Barthell pre-admission function, n (%)

  < 50

72

(8.8)

26

(5.9)

24

(11.8)*

14

(7.9)

Mortality

 In-Patient

42

(5.1)

18

(4.1)

12

(6)

12

(6.7)

 3mo

122

(14.8)

54

(12.3)

38

(19)

22

(12.4)

 12mo

164

(20.0)

76

(17.3)

38

(19)

38

(21.3)

  1. *p < 0.01 vs the HIV-uninfected group
  2. TB Tuberculosis, CCF Congestive cardiac failure, COPD Chronic obstructive pulmonary disease
Back to article page

BMC Palliative Care

ISSN: 1472-684X

Contact us